Control Bionics Limited (ASX:CBL)
Australia · Delayed Price · Currency is AUD 0.0550
-0.0050 (-8.33%)
Apr 28, 2026, 3:43 PM AEST
Control Bionics Market Cap
Control Bionics has a market cap or net worth of 22.66 million as of April 28, 2026. Its market cap has increased by 45.03% in one year.
Market Cap
22.66M
Enterprise Value
19.84M
Revenue
6.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.06
Market Cap Chart
Since December 7, 2020, Control Bionics's market cap has decreased from 98.33M to 22.66M, a decrease of -76.96%. That is a compound annual growth rate of -23.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 22.66M | -7.95% |
| Dec 31, 2025 | 24.61M | 62.80% |
| Dec 31, 2024 | 15.12M | 126.88% |
| Dec 29, 2023 | 6.66M | -55.36% |
| Dec 30, 2022 | 14.93M | -59.58% |
| Dec 30, 2021 | 36.94M | -52.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 7, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HeraMED | 56.59M |
| Micro-X | 39.24M |
| Nova Eye Medical | 38.45M |
| CleanSpace Holdings | 34.33M |
| ImpediMed | 28.54M |
| CurveBeam AI | 28.19M |
| Atomo Diagnostics | 24.33M |
| CONNEQT Health | 21.43M |